Lv4
630 积分 2022-11-24 加入
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
19小时前
已完结
Global burden of metabolic diseases, 1990–2021
19小时前
已完结
Spatiotemporal burden, risk factors, and genetic causality of non‐alcoholic fatty liver disease and type 2 diabetes mellitus comorbidity in Europe: A multi‐database analysis
20小时前
已完结
Obesity and Depression
1天前
已完结
Insulin resistance: The role in comorbid type 2 diabetes mellitus and depression
1天前
已完结
Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities
1天前
已完结
Shengmai Yin Alleviates Particulate Matter-Aggravated Ischemic Damage by Inhibiting S100a9 Expression
1天前
已完结
Research progress of epidermal growth factor receptor in metabolic dysfunction‐associated steatotic liver disease and related diseases
1天前
已完结
PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach
1天前
已完结
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases
1天前
已完结
皖公网安备34019202002308
